Back to Search Start Over

Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA

Authors :
Butler, Javed
Zheng, Yinggan
Khan, Muhammad Shahzeb
Bonderman, Diana
Lund, Lars H.
deFilippi, Christopher R.
Blaustein, Robert O.
Ezekowitz, Justin A.
Freitas, Cecilia
Hernandez, Adrian F.
O’Connor, Christopher M.
Voors, Adriaan A.
Westerhout, Cynthia M.
Lam, Carolyn S.P.
Armstrong, Paul W.
Source :
JACC: Heart Failure; May 2023, Vol. 11 Issue: 5 p583-592, 10p
Publication Year :
2023

Abstract

Vericiguat reduced the risk of cardiovascular death (CVD) or hospitalization for heart failure (HF) in patients with worsening HF and reduced left ventricular ejection fraction (LVEF).

Details

Language :
English
ISSN :
22131779
Volume :
11
Issue :
5
Database :
Supplemental Index
Journal :
JACC: Heart Failure
Publication Type :
Periodical
Accession number :
ejs62868638
Full Text :
https://doi.org/10.1016/j.jchf.2022.12.014